This company is delisted or no longer publicly traded. The analysis below is archived and will not be updated.

Lipum AB (publ) LIPUM

Updated: 10 Aug 2026

First North | Biotech | Biotechnology
Free
No email, no account, no signup.
Exchange
First North
Type
Biotech
Sector
Biotechnology
We're already tracking Lipum AB (publ) — here are the latest events we've registered

Recent News

  • On July 6, 2026, Lipum announced the peer-reviewed publication of positive Phase I trial results for SOL-116. Earlier in March 2026, the company completed its merger with Flerie AB and was subsequently delisted from Nasdaq First North. Lipum has also secured EU funding through Horizon Europe to support its upcoming Phase IIa study.

What Firelda Watch includes for Lipum AB (publ)

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Lipum AB (publ) will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Xbrane Biopharma AB (publ)
XBRANE
HOLD
SynAct Pharma AB
SYNACT
HOLD

Biotech

More companies in this sector

Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.